← Back to Search

Smoking Cessation Agent

Varenicline for Vaping (VAPEscape Trial)

Q: Can individuals who are above the age of forty participate in this research?

This clinical trial is open to individuals aged 18-65. For those outside of this age range, there are 7 trials available for minors and 29 studies targeting seniors.

Q: How many individuals may partake in this clinical research?

Unfortunately, this medical trial is not open to new participants as of now. It was initially posted on May 1st 2023 and its last update occurred in June 2022. However, if you are searching for different research opportunities there are 13 vaping studies currently recruiting and 26 more trials seeking patients that use Varenicline.

Q: What other experimental studies have been conducted utilizing Varenicline?

Currently, 26 active clinical trials for Varenicline with 4 in the late-stage of research exist. The majority of these are based out of Charleston, <a href="https://www.withpower.com/clinical-trials/south-carolina">South carolina</a> though there are 69 total locations conducting experiments with this medication.

Q: Are there still opportunities for certain individuals to join this medical research?

Clinicaltrials.gov does not have this trial listed as actively recruiting at the moment; it was posted on May 1st 2023 and last edited on June 9th 2022. However, there are currently 39 other medical studies that are looking for individuals to participate in their trials.

Q: May I participate in this medical research experiment?

Individuals between 18 and 65 that partake in vaping are eligible to join this research project. Currently, 20 participants have been identified to take part in the trial.

Phase < 1

Waitlist Available

Led By Jon Ebbert, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

VAPEscape Trial Summary

This trial is to see if 12 weeks of varenicline (Chantix) could help e-cigarette users quit.

VAPEscape Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of e-cigarette abstinence after 12 weeks of treatment with varenicline plus brief behavioral therapy as an aid to stop vaping

Side effects data

From 2022 Phase 4 trial • 39 Patients • NCT04011280

50%

Dysgeusia

50%

Anxiety

36%

Sleep Disturbances

29%

Nausea

21%

Headache

21%

Agitation

21%

Depression

14%

Allergies

14%

Heartburn

14%

Cold

14%

Back Pain

Sinusitis

Palpitations

Fatigue

Leg Spasms

Angina

Rash

Aggression

Panic

Confusion

Stomach Pain

Dizziness

Cellulitis

Increased Blood Pressure

Malaise

Weight Gain

Gum Disease

Pharyngitis

Leg Cramps

Muscle Pain

100%

80%

60%

40%

20%

Study treatment Arm

Low Dose Varenicline

Standard Dose Varenicline

VAPEscape Trial Design

1Treatment groups

Experimental Treatment

Group I: E-cigarette usersExperimental Treatment2 Interventions

Participants who are regular users of e-cigarettes will be treated with a 12 week course of varenicline for stopping vaping.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Varenicline

2011

Completed Phase 4

~4170

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,202 Previous Clinical Trials

3,761,931 Total Patients Enrolled

Jon Ebbert, MDPrincipal InvestigatorMayo Clinic

J Taylor T Hays, MDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals who are above the age of forty participate in this research?

"This clinical trial is open to individuals aged 18-65. For those outside of this age range, there are 7 trials available for minors and 29 studies targeting seniors."

Answered by AI

How many individuals may partake in this clinical research?

"Unfortunately, this medical trial is not open to new participants as of now. It was initially posted on May 1st 2023 and its last update occurred in June 2022. However, if you are searching for different research opportunities there are 13 vaping studies currently recruiting and 26 more trials seeking patients that use Varenicline."

Answered by AI

What other experimental studies have been conducted utilizing Varenicline?

"Currently, 26 active clinical trials for Varenicline with 4 in the late-stage of research exist. The majority of these are based out of Charleston, South carolina though there are 69 total locations conducting experiments with this medication."

Answered by AI

Are there still opportunities for certain individuals to join this medical research?

"Clinicaltrials.gov does not have this trial listed as actively recruiting at the moment; it was posted on May 1st 2023 and last edited on June 9th 2022. However, there are currently 39 other medical studies that are looking for individuals to participate in their trials."

Answered by AI

May I participate in this medical research experiment?

"Individuals between 18 and 65 that partake in vaping are eligible to join this research project. Currently, 20 participants have been identified to take part in the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Treatment for Vaping Cessation

Jon Ebbert 2023. "Feasibility of Treatment for Vaping Cessation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04317300.